Home Cart Sign in  
Chemical Structure| 138-59-0 Chemical Structure| 138-59-0

Structure of Shikimic acid
CAS No.: 138-59-0

Chemical Structure| 138-59-0

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Shikimic acid(Shikimate), more commonly known as its anionic form shikimate, is an important biochemical intermediate in plants and microorganisms.

Synonyms: NSC 59257; Shikimate; (–)-Shikimic Acid, L-Shikimic Acid, Shikimic acid

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Shikimic acid

CAS No. :138-59-0
Formula : C7H10O5
M.W : 174.15
SMILES Code : O[C@H]1[C@H](O)[C@H](O)C=C(C(O)=O)C1
Synonyms :
NSC 59257; Shikimate; (–)-Shikimic Acid, L-Shikimic Acid, Shikimic acid
MDL No. :MFCD00066278
InChI Key :JXOHGGNKMLTUBP-HSUXUTPPSA-N
Pubchem ID :8742

Safety of Shikimic acid

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

Description
Shikimic acid is a pivotal intermediate in the biosynthesis of aromatic amino acids found in microorganisms and plants.

In Vitro:

Cell Line
Concentration Treated Time Description References
3T3-L1 cells 0, 10, 20, 40, 80, 160 µM 24 hours Evaluate the cytotoxicity of shikimic acid in 3T3-L1 cells, showing cell viability remained above 70% at 160 μM concentration. Int J Mol Sci. 2019 Jan 29;20(3):582
Huh7 cells 0, 10, 20, 40, 80, 160 µM 24 hours Evaluate the cytotoxicity of shikimic acid in Huh7 cells, showing cell viability remained above 70% at 160 μM concentration. Int J Mol Sci. 2019 Jan 29;20(3):582
HepG2 cells 0, 10, 20, 40, 80, 160 µM 24 hours Evaluate the cytotoxicity of shikimic acid in HepG2 cells, showing cell viability remained above 70% at 160 μM concentration. Int J Mol Sci. 2019 Jan 29;20(3):582
BV2 cells 5 µM and 10 µM 24 hours SA inhibited the production of NO and ROS in LPS-stimulated BV2 cells Front Pharmacol. 2023 Nov 2;14:1265571
SW1353 human chondrocytes 10 mM 24 hours To evaluate the effects of SA on IL-1β-induced inflammatory response and cartilage degradation. SA significantly alleviated the IL-1β-induced increases in iNOS, COX-2, MMP3, MMP13, ADAMTS5, and type X collagen expression and restored type II collagen expression. Front Pharmacol. 2021 Jul 27;12:634822
HL-1 cells 250 µM to 31.25 µM 24 hours Promoted proliferation of normal HL-1 cells by an average of 31.0% Pharmaceuticals (Basel). 2024 Nov 5;17(11):1485
LLC-PK1 cells 25 and 50 µM 24 hours To evaluate the protective effect of shikimic acid against cisplatin-induced renal cell damage. Results showed that shikimic acid reversed the decrease in cell viability induced by cisplatin and reduced oxidative stress and apoptosis. Plants (Basel). 2020 Dec 1;9(12):1681
Human dermal fibroblasts (HDFs) 25 mM 24 hours To evaluate the protective effect of shikimic acid against UV-induced cellular senescence, results showed that shikimic acid reduced the levels of H4K16ac and H3K9ac by activating SIRT1, thereby inhibiting cellular senescence. Aging (Albany NY). 2021 Apr 26;13(9):12308-12333
HL-1 cells 250 µM to 31.25 µM 3 hours Enhanced survival rate of HL-1 cells exposed to heat stress by approximately 59.9%, downregulated expression of Hsp90 and Hsp70 Pharmaceuticals (Basel). 2024 Nov 5;17(11):1485
Duck myofibrillar protein 1:50,000, 1:25,000, 1:12,500, 1:6250 (g/g) 30 minutes To study the effect of shikimic acid on the oxidation and structure of duck myofibrillar protein. Results showed that shikimic acid significantly reduced protein oxidation and improved thermal stability. Foods. 2024 Oct 21;13(20):3338
Primary rat chondrocytes 10 mM 48 hours To evaluate the effects of SA on IL-1β-induced chondrocyte degeneration. SA significantly attenuated IL-1β-associated degeneration and matrix disruption. Front Pharmacol. 2021 Jul 27;12:634822

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
C57BL/6J mice DSS-induced ulcerative colitis model Intragastric administration 10, 30, 50 mg/kg Once daily for 8 days To evaluate the therapeutic effects of SA on DSS-induced colitis, results showed SA slowed weight loss, reduced DAI score, enhanced intestinal barrier function, reduced colonic structure destruction, inhibited phosphorylation of key proteins in MAPK and NF-κB signaling pathways, inhibited expression of inflammatory factors TNF-α, IL-1β, and MPO, decreased IFN-γ expression, and increased IgG content. Additionally, 50 mg/kg SA treatment increased Bacteroidetes and decreased Proteobacteria in cecal feces of colitis mice and increased gut species richness. J Agric Food Chem. 2023 Jun 14;71(23):8906-8914
C57/BL6 mice LPS-induced neuroinflammation model Intraperitoneal injection 100 mg/kg Once daily for 4 weeks SA ameliorated the neurological damage and behavioral deficits caused by LPS injection in mice Front Pharmacol. 2023 Nov 2;14:1265571
Rats Sprague Dawley rats Intravenous and intragastric 2 mg/kg iv, 100 mg/kg ig Single dose To study the pharmacokinetic behavior of shikimic acid in rats. After iv administration, shikimic acid exhibited bi-exponential decay with rapid distribution (5.57 h?1) up to 1 h followed by slow elimination (0.78 h?1). After ig administration, the plasma shikimic acid level peaked at about 3 h and then declined mono-exponentially (half-life =1.3 h). The absolute oral bioavailability was about 10%. Pharmaceutics. 2020 Aug 29;12(9):824
Sprague Dawley rats ACLT-induced osteoarthritis model Intra-articular injection 20 mM Twice a week for one month To evaluate the effects of SA on the progression of osteoarthritis. SA treatment alleviated the progression of OA, as evidenced by reduced articular cartilage erosion and loss of safranin O staining and toluidine blue staining. Front Pharmacol. 2021 Jul 27;12:634822
BALB/c mice Cisplatin-induced acute kidney injury model Oral 25 and 50 mg/kg Once daily for 4 days To assess the protective effect of shikimic acid against cisplatin-induced kidney injury. Results showed that shikimic acid reduced serum creatinine levels and improved histological kidney injury. Plants (Basel). 2020 Dec 1;9(12):1681
Growing pigs Healthy growing pigs Intragastric and intravenous 50 mg/kg (intragastric), 2 mg/kg (intravenous) Single dose, observed for 24 hours To study the pharmacokinetics of shikimic acid in pigs and its impact on humoral immunity. Results showed rapid absorption after intragastric administration, with a plasma Cmax of 10,823.44 ng/mL and t1/2 of 1.81 h. Intravenous administration followed a two-compartment open model with t1/2 of 3.66 h. Absolute bioavailability was 21.68%. SA plasma concentration showed strong positive correlation with changes in C3, C4, IgG, IgA, and IgM (0.6 < R < 1, P < 0.0001). J Agric Food Chem. 2024 Nov 27;72(47):26224-26235
Growing pigs Healthy growing pigs Intragastric and intravenous administration 50 mg/kg (intragastric), 2 mg/kg (intravenous) Single dose, observed for 24 hours To study the pharmacokinetics of shikimic acid in pigs and its impact on humoral immunity. Results showed that SA was rapidly absorbed after intragastric administration, with a plasma Cmax of 10,823.44 ng/mL and t1/2 of 1.81 h; intravenous administration followed a two-compartment open model with t1/2 of 3.66 h. The absolute bioavailability was 21.68%. Additionally, SA concentration showed a strong positive correlation with changes in C3, C4, IgG, IgA, and IgM (0.6 < R < 1, P < 0.0001). J Agric Food Chem. 2024 Nov 27;72(47):26224-26235
Tomato (Solanum lycopersicum L.) Tomato plants Seed soaking 60 ppm Single treatment, lasting the entire growing season To study the effects of shikimic acid on the growth, yield, and fruit quality of tomato under cold stress. Results showed that shikimic acid treatment improved plant growth parameters, yield, and fruit quality. Plants (Basel). 2022 Oct 24;11(21):2822

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

5.74mL

1.15mL

0.57mL

28.71mL

5.74mL

2.87mL

57.42mL

11.48mL

5.74mL

Dissolving Methods
The prepared working fluid is recommended to be prepared now and used up as soon as possible in a short period of time. The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1

References

 

Historical Records

Categories